Brain, Vol. 123, No. 12, 2423-2431,
December 2000
© 2000 Oxford University Press
Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence
Academic Department of Radiology and 1 Section of Clinical Neurology, University of Sheffield, Sheffield, UK
Correspondence to:
Dr R. A. Grünewald, Section of Clinical Neurology, N Floor, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK E-mail: ra.grunewald{at}sheffield.ac.uk
Iron content of the basal ganglia was investigated in 25 patients with idiopathic Parkinson's disease and 14 matched healthy control subjects using a partially refocused interleaved multiple echo sequence on a 1.5 Tesla MRI system. R2* (1/T2*) and R2' (1/T2') relaxation rates were higher in the substantia nigra of patients with Parkinson's disease, which indicates that iron content is elevated in this region. R2' was lower in the putamen, indicating reduced iron levels; reduction in this region was positively correlated with disease duration. Iron-related oxidative stress may contribute to the neurodegeneration of Parkinson's disease, which may lead to alterations in the iron levels of the striatum. We describe a simple, non-invasive technique for measuring iron content.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
W. R. W. Martin, M. Wieler, and M. Gee Midbrain iron content in early Parkinson disease: A potential biomarker of disease status Neurology, April 15, 2008; 70(16_Part_2): 1411 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, S. Xiong, H. She, S. W. Lin, J. Wang, and H. Tsukamoto Iron Causes Interactions of TAK1, p21ras, and Phosphatidylinositol 3-Kinase in Caveolae to Activate I{kappa}B Kinase in Hepatic Macrophages J. Biol. Chem., February 23, 2007; 282(8): 5582 - 5588. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Minati, M. Grisoli, F. Carella, T. De Simone, M.G. Bruzzone, and M. Savoiardo Imaging Degeneration of the Substantia Nigra in Parkinson Disease with Inversion-Recovery MR Imaging AJNR Am. J. Neuroradiol., February 1, 2007; 28(2): 309 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Wood, C. Enriquez, N. Ghugre, J. M. Tyzka, S. Carson, M. D. Nelson, and T. D. Coates MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients Blood, August 15, 2005; 106(4): 1460 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Haba-Rubio, L Staner, C Petiau, G Erb, T Schunck, and J P Macher Restless legs syndrome and low brain iron levels in patients with haemochromatosis J. Neurol. Neurosurg. Psychiatry, July 1, 2005; 76(7): 1009 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Graham, N. Papadakis, J. Evans, E. Widjaja, C. A.J. Romanowski, M. N.J. Paley, L. I. Wallis, I. D. Wilkinson, P. J. Shaw, and P. D. Griffiths Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS Neurology, December 14, 2004; 63(11): 2111 - 2119. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Symms, H R Jager, K Schmierer, and T A Yousry A review of structural magnetic resonance neuroimaging J. Neurol. Neurosurg. Psychiatry, September 1, 2004; 75(9): 1235 - 1244. [Abstract] [Full Text] [PDF] |
||||




